Advertisement

An Elite Athlete with Controversial Left Ventricular Hypertrophy

  • Barbara Di Giacinto
  • Fernando Maria Di Paolo
  • Antonio Pelliccia
Chapter

Patient

This 17-year-old male athlete underwent cardiovascular evaluation in our Institute for the first time in 1995, selected as member of the national swimming team, based on his excellent athletic results. In the personal history no cardiac symptoms or previous cardiovascular diseases were reported. The family history was negative for known cardiovascular diseases and sudden cardiac death in close relatives.

Keywords

Cardiac Magnetic Resonance Left Ventricular Hypertrophy Left Ventricular Systolic Function Left Ventricular Cavity Maximum Wall Thickness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Pelliccia A, Fagard R, Bjornstad HH, Anastassakis A, Arbustini E, Assanelli D, Biffi A, Borjesson M, Carre F, Corrado D, Delise P, Dorwarth U, Hirth A, Heidbuchel H, Hoffmann E, Melwig KP, Panhuyzen-Goedkoop NM, Pisani A, Solberg EE, Vanbuuuren F, Vanhees L. Recommendations for competitive sports participation in athletes with cardiovascular disease. Eur Heart J 2005, 26:1422−1445PubMedCrossRefGoogle Scholar
  2. 2.
    Maron BJ, Zipes Douglas P. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities. JACC 2005, 45(8):1318−1321.PubMedGoogle Scholar
  3. 3.
    Panza JA, Maron BJ. Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood. Am J Cardiol 1989, 63:1258−1265PubMedCrossRefGoogle Scholar
  4. 4.
    Montgomery JV, Harris KM, Casey SA, Zenovich AG, Maron BJ. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol 2005, 96:270−275PubMedCrossRefGoogle Scholar
  5. 5.
    Pelliccia A, Di Paolo FM, Quattrini FM, et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med Jan 10 2008, 358(2):152−161CrossRefGoogle Scholar
  6. 6.
    Pelliccia A, Maron A, Maron J, et al. The upper limits of physiological cardiac hypertrophy in highly trained elite athletes. N Engl J Med Jan 31 1991, 324(5):295−301CrossRefGoogle Scholar
  7. 7.
    Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports including sudden death. Circulation 2006, 114:1633−1644PubMedCrossRefGoogle Scholar
  8. 8.
    Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005, 112:855−861PubMedCrossRefGoogle Scholar
  9. 9.
    Maron BJ, Niimura H, Casey SA, Soper MK, Wright GB, Seidman JG, Seidman CE. Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 2001, 38:315−321PubMedCrossRefGoogle Scholar
  10. 10.
    Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003, 107(17):2171−2174CrossRefGoogle Scholar
  11. 11.
    Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sport activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003, 42:1959−1963PubMedCrossRefGoogle Scholar
  12. 12.
    British Broadcasting Cooperation. Midfielder Marc-Vivien Foe dies after collapsing during an international in France. news.bbc.co.uk/sport1/hi/football/3024360.stmGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2009

Authors and Affiliations

  • Barbara Di Giacinto
    • 1
  • Fernando Maria Di Paolo
    • 2
  • Antonio Pelliccia
    • 3
  1. 1.Institute of Sport Medicine and Science, Italian National Olympic CommitteeDepartment of Sport Medicine, Largo Piero Gabrielli1 00197 RomeItaly
  2. 2.Institute of Sport Medicine and Science, Italian National Olympic CommitteeDepartment of MedicineRomeItaly
  3. 3.Institute of Sport Medicine and Science, Italian National Olympic CommitteeDepartment of Medicine, Largo Piero GabrielliRomeItaly

Personalised recommendations